Thermopylae Holdings Ltd. - 13 Jun 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
10%+ Owner
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
13 Jun 2022
Net transactions value
+$514,908
Form type
4
Filing time
15 Jun 2022, 13:14:45 UTC
Previous filing
08 Jun 2022
Next filing
22 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $441,066 +54,915 +0.1% $8.03 55,635,218 13 Jun 2022 Direct F1
transaction ABCL Common Shares Purchase $73,842 +9,173 +0.02% $8.05 55,644,391 14 Jun 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $7.99 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $8.045 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.